Bruce & Co., Inc. portfolio
Latest available portfolio: Q2 2026 · Holdings as of · Filed · in Form 13F holdings
See latest portfolio changes
$369.5M
Full value: $369,495,763 · USD · 30 Jun 2026Quarterly portfolio filings
Choose a quarter to see holdings and changes. Newer portfolio dates appear first.
Estimated additions and reductions value share changes at filing-derived prices; they are not actual trade proceeds or costs.
| Quarter | Holdings | SEC-reported value | Est. additions | Est. reductions | Est. net | Top Holdings | Form Type | Accepted by SEC |
|---|---|---|---|---|---|---|---|---|
| Q2 2026 | 41 | $369,495,763 | +$4,886,220 | -$12,032,337 | -$7,146,117 | ABBV, ALL, AER, FPL, Merck | 13F-HR | 14 Aug 2026, 10:57 |
| Q1 2026 | 41 | $349,664,799 | +$8,192,007 | -$7,820,000 | +$372,007 | FPL, ABBV, ALL, AER, Merck | 13F-HR | 14 May 2026, 14:33 |
| Q4 2025 | 39 | $322,530,845 | $0 | -$9,498,277 | -$9,498,277 | ABBV, AER, ALL, FPL, UHALB | 13F-HR | 13 Feb 2026, 16:28 |
| Q3 2025 | 39 | $322,942,390 | +$1,358,800 | -$11,969,677 | -$10,610,877 | ABBV, ALL, FPL, UHALB, AER | 13F-HR | 13 Nov 2025, 15:19 |
| Q2 2025 | 41 | $308,468,802 | +$3,794,100 | -$3,964,278 | -$170,178 | ALL, UHALB, ABBV, Nextera Energy, AER | 13F-HR | 14 Aug 2025, 11:25 |
| Q1 2025 | 42 | $311,828,143 | +$8,955,427 | -$17,130,775 | -$8,175,348 | UHALB, ABBV, ALL, Nextera Energy, DUK | 13F-HR | 14 May 2025, 11:54 |
| Q4 2024 | 41 | $311,425,174 | +$8,275,122 | -$19,144,538 | -$10,869,416 | UHALB, ALL, ABBV, FPL, Merck | 13F-HR | 11 Feb 2025, 11:08 |
| Q3 2024 | 41 | $343,599,745 | +$15,533,960 | -$21,195,599 | -$5,661,639 | UHALB, ABBV, FPL, ALL, Merck | 13F-HR | 14 Nov 2024, 13:32 |
| Q2 2024 | 40 | $303,972,345 | +$20,004,262 | -$655,180 | +$19,349,082 | UHALB, Merck, ABBV, FPL, ALL | 13F-HR | 09 Aug 2024, 13:18 |
| Q1 2024 | 39 | $301,495,484 | +$9,305,200 | -$8,505,240 | +$799,960 | UHALB, Merck, ABBV, ALL, DUK | 13F-HR | 13 May 2024, 14:41 |
| Q4 2023 | 37 | $286,579,366 | +$4,301,319 | -$40,428,555 | -$36,127,236 | UHALB, Merck, ABBV, DUK, XEL | 13F-HR | 12 Feb 2024, 12:57 |
| Q3 2023 | 38 | $293,432,047 | +$5,374,550 | -$45,757,634 | -$40,383,084 | UHALB, ABBV, Merck, XEL, CMS | 13F-HR | 13 Nov 2023, 08:49 |
| Q2 2023 | 37 | $356,489,671 | +$3,683,000 | -$3,902,175 | -$219,175 | Merck, UHALB, ABBV, FPL, CMS | 13F-HR | 08 Aug 2023, 12:51 |
| Q1 2023 | 37 | $366,935,772 | +$7,469,316 | -$8,409,054 | -$939,738 | UHALB, Merck, ABBV, FPL, CMS | 13F-HR | 12 May 2023, 17:13 |
| Q4 2022 | 37 | $387,902,785 | +$38,389,878 | -$16,883,794 | +$21,506,084 | UHALB, Merck, ABBV, FPL, PFE | 13F-HR | 14 Feb 2023, 18:19 |
| Q3 2022 | 34 | $363,879,000 | +$9,569,933 | -$42,238,346 | -$32,668,413 | UHAL, ABBV, ALL, Merck, FPL | 13F-HR | 15 Nov 2022, 11:30 |
| Q2 2022 | 33 | $425,070,000 | +$3,033,822 | -$10,617,632 | -$7,583,810 | UHAL, FPL, ABBV, ALL, DUK | 13F-HR | 08 Aug 2022, 18:20 |
| Q1 2022 | 32 | $489,080,000 | +$24,104,564 | -$25,973,090 | -$1,868,526 | UHAL, FPL, ABBV, ALL, CMS | 13F-HR | 11 May 2022, 15:03 |
| Q4 2021 | 31 | $500,144,000 | +$448,967 | -$18,729,038 | -$18,280,071 | UHAL, FPL, ABBV, VRX, ALL | 13F-HR | 16 Feb 2022, 16:19 |
| Q3 2021 | 31 | $470,676,000 | +$8,508,734 | -$131,875,611 | -$123,366,877 | UHAL, FPL, VRX, ALL, AAPL | 13F-HR | 12 Nov 2021, 17:10 |
| Q2 2021 | 31 | $523,621,000 | +$6,430,594 | -$23,521,983 | -$17,091,389 | UHAL, ALL, VRX, ABBV, FPL | 13F-HR | 16 Aug 2021, 12:12 |
| Q1 2021 | 35 | $533,784,000 | +$11,480,679 | -$46,871,007 | -$35,390,328 | UHAL, VRX, FPL, ABBV, ALL | 13F-HR | 17 May 2021, 14:34 |
| Q4 2020 | 39 | $518,789,000 | +$38,089,269 | -$27,432,639 | +$10,656,630 | UHAL, FPL, AAPL, ALL, ABBV | 13F-HR | 16 Feb 2021, 06:43 |
| Q3 2020 | 41 | $475,657,000 | +$28,123,189 | -$7,434,422 | +$20,688,767 | UHAL, FPL, AAPL, CMS, XEL | 13F-HR | 13 Nov 2020, 15:32 |
| Q2 2020 | 40 | $452,641,000 | +$17,504,487 | -$22,474,941 | -$4,970,454 | UHAL, FPL, AAPL, ABBV, ALL | 13F-HR | 14 Aug 2020, 16:06 |
Showing 1-25 of 51 filings.
Manager details and filing context
- Latest 13F filing
- Q2 2026 - 14 Aug 2026
- Latest reported 13F value
- $369,495,763
- Largest 13F holdings
-
ABBV ALL AER FPL Merck UHALB DUK VICR XEL CMS T AAPL
+8 more
BBNX IIIN ABT NEM AVA ADM BG SUPN - Form 13F summary
-
- Bruce & Co., Inc. Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
- Form 13F is generally due within 45 days after each calendar quarter ends.
- Bruce & Co., Inc. reported 41 equity holdings with a total reported market value of $369,495,763 for Q2 2026. Top reported holdings included ABBV, ALL, AER, FPL, and Merck.
- Manager signature
- R. Jeffrey Bruce - President
- Manager location
- Chicago, IL
13F snapshot
Latest parsed holdings, value, and filing-period context.
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Holdings Value